Related Experiment Video
Updated: Aug 29, 2026
Laparoscopic Extracorporeal Knot-Tying for Uterine Vessel Occlusion during Hysterectomy with Cervical Cerclage in Large Uteri
Published on: September 12, 2025
Insights
Uterine artery embolization (UAE) offers short-term relief for uterine fibroid symptoms like heavy bleeding. However, its safety for fertility preservation and pregnancy outcomes requires more research, with experts recommending careful evaluation.
Area of Science:
- Gynecology
- Interventional Radiology
Background:
- Uterine leiomyomata (fibroids) are common, causing symptomatic issues like bulk and heavy menstrual bleeding.
- Uterine artery embolization (UAE) is an increasingly utilized minimally invasive treatment for symptomatic uterine fibroids.
Framework:
- Current evidence suggests UAE provides effective short-term symptom relief and reduces menstrual flow when performed by experienced physicians.
- Complication rates are generally low, but severe outcomes such as hysterectomy and death are rare possibilities.
Implementation:
- The procedure's safety and efficacy in women desiring future fertility remain understudied, with limited data on pregnancy-related outcomes.
- The American College of Obstetricians and Gynecologists advises caution, considering UAE investigational or relatively contraindicated in women wishing to retain fertility.
Implications:
- UAE is rarely indicated for postmenopausal women.
- Comprehensive pre-procedural evaluation with an obstetrician-gynecologist is strongly recommended to ensure appropriate patient selection and facilitate collaboration with interventional radiologists.
- Informed consent regarding potential complications is crucial for all patients considering UAE.
Abstract:
Uterine artery embolization for the treatment of symptomatic uterine leiomyomata has become increasingly popular. Based on current evidence, it appears that uterine artery embolization, when performed by experienced physicians, provides good short-term relief of bulk-related symptoms and a reduction in menstrual flow. Complication rates associated with the procedure are low, but in rare cases can include hysterectomy and death. There is insufficient evidence to ensure its safety in women desiring to retain their fertility, and pregnancy-related outcomes remain understudied. The American College of Obstetricians and Gynecologists' Committee on Gynecologic Practice considers the procedure investigational or relatively contra-indicated in women wishing to retain fertility. The use of uterine artery embolization in postmenopausal women is rarely, if ever, indicated. The Committee strongly recommends that women who wish to undergo uterine artery embolization have a thorough evaluation with an obstetrician-gynecologist to help facilitate optimal collaboration with interventional radiologists and to ensure the appropriateness of this therapy, taking into account the reproductive wishes of the patient. It is also recommended that all patients considering uterine artery embolization be adequately informed about potential complications.
